Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of Disease-modifying Treatments on Long-term Changes in the Choroid Plexus in Subjects With Radiologically Isolated Syndrome

Author:LANDES-CHATEAU, Cassandre   Stankoff, Bruno   Ricigliano, Vito AG   Mondot, Lydiane   Cohen, Mikael   YAZDAN PANAH, ARYA   Kantarci, Orhun   Okuda, Darin   Lebrun Frenay, Christine   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.008  

Author Institution:Nice University Hospital, France  Hopital De La Pitie Salpetriere, Paris, France  Hôpital Paris-Saclay, Orsay, France  Nice University Hospital, Nice, France  Institut du Cerveau et de la Moelle, Paris, France  Mayo Clinic, Rochester, MN  UT Southwestern Medical Center, Dallas, TX  

Cladribine for the Treatment of Relapsing Multiple Sclerosis: The Northern Ireland Experience

Author:Philson, Emma   Kee, Rachael   McKee, Jon   Campbell, Jamie   Gray, Orla   McDonnell, Gavin   Hughes, Stella   Kennedy, Fiona   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.008  

Author Institution:Belfast Health and Social Care Trust, Belfast, United Kingdom  Southern Health and Social Care Trust, United Kingdom  South Eastern Health and Social Care Trust, United Kingdom  

Long-term Treatment Effects of Frexalimab on NfL, CXCL13, and Brain Volume Loss in Relapsing Multiple Sclerosis

Author:Granziera, Cristina   Vermersch, Patrick   Djukic, Biljana   Geertsen, Svend S.   Shafer, Andrea T.   Truffinet, Philippe   Giovannoni, Gavin   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine  Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland  University of Lille, Inserm U1172, Lille Neuroscience and Cognition, CHU Lille, FHU Precise, Lille, France, Lille, France  Sanofi, Cambridge, MA, USA, Cambridge, MA  Sanofi, Gentilly, France, Gentilly, France  Queen Mary University of London, London, UK, London, United Kingdom  

Longitudinal Lymphocyte, CD3, and Neutrophil Counts as Predictive Biomarkers for Infection Risk Following Anti-CD20 Therapy in Patients With MS

Author:Dodson, Cory   Jamal, Yaseen   Han, May   

Session Name:P4: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 1  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Stanford Neurology, Palo Alto, CA  Stanford, CA  Stanford University, Stanford, CA  

Rituximab in Demyelinating Disorders of the Central Nervous System: Real-world Insights From a Tertiary Institute in Pakistan

Author:Nishat, Sadia   Sheerani, Mughis   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution:Sindh Institute of Urology and Transplantation, Karachi, Pakistan  Neurogym, Karachi, Pakistan